title: Independent data about the safety and efficacy of rivaroxaban for prevention of stroke/embolism are needed.
authors.affiliation: Krankenanstalt Rudolfstiftung, Juchgasse 25, Wien A-1030, Austria claudia.stoellberger@chello.at.
authors.forename: Claudia
authors.initials: C
authors.lastname: Stöllberger
authors.affiliation: Gesundheitszentrum Oberammergau, Klinik am Kofel. Hubertusstr. 2, Oberammergau D-82487, Germany.
authors.forename: Peter
authors.initials: P
authors.lastname: Pommer
authors.affiliation: Medizinische Klinik II, Kardiologie und Angiologie, Sana Kliniken Lübeck, Kronsforder Allee 71, Lübeck D-23560, Germany.
authors.forename: Birke
authors.initials: B
authors.lastname: Schneider
authors.affiliation: Krankenanstalt Rudolfstiftung, Juchgasse 25, Wien A-1030, Austria.
authors.forename: Josef
authors.initials: J
authors.lastname: Finsterer
mesh_terms: D001281:Atrial Fibrillation / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D012042:Registries; D000069552:Rivaroxaban / Q000008:administration & dosage*; D020521:Stroke / Q000517:prevention & control*; D028761:Withholding Treatment / Q000706:statistics & numerical data*
chemical_list: D000069552:Rivaroxaban